An unloved health-care stock gets a welcome nod in this AI-obsessed market
CNBC Top News ·
Health-care stocks aren't getting much of a look in this AI-driven market. That makes a Wall Street upgrade of Johnson & Johnson a bit of an outlier — and a pleasant surprise. …
Health-care stocks aren't getting much of a look in this AI-driven market. That makes a Wall Street upgrade of Johnson & Johnson a bit of an outlier — and a pleasant surprise. Leerink analysts lifted J & J shares to a buy equivalent from hold on Wednesday, citing the company's slate of new drugs, including Icotyde, a medicine for severe plaque psoriasis, and Inlexzo, which treats bladder cancer. …
Original source: CNBC Top News